Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
about
Circadian regulation of low density lipoprotein receptor promoter activity by CLOCK/BMAL1, Hes1 and Hes6Targeted therapy for hepatocellular carcinoma: novel agents on the horizonNOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cellsCancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells.Hepatitis C virus NS3 protein can activate the Notch-signaling pathway through binding to a transcription factor, SRCAP.Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinomaNovel therapeutic strategies for targeting liver cancer stem cells.Notch signaling proteins: legitimate targets for cancer therapy.Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2.Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell nicheIdentification of Cellular Targets of MicroRNA-181a in HepG2 Cells: A New Approach for Functional Analysis of MicroRNAs.IKKα activation of NOTCH links tumorigenesis via FOXA2 suppression.The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling.Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection.SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma.Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma.Cancer stem cells and hepatocellular carcinomaSignaling pathways in hepatocellular carcinoma.Pathways involved in Drosophila and human cancer development: the Notch, Hedgehog, Wingless, Runt, and Trithorax pathway.Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses.The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Notch in fibrosis and as a target of anti-fibrotic therapy.Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives.Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2.Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinomaNotch Signaling in Development, Tissue Homeostasis, and Disease.Crosstalk between the Notch signaling pathway and non-coding RNAs in gastrointestinal cancers.Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt.Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.LncRNAs as novel players in hepatocellular carcinoma recurrenceDelta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
P2860
Q24606118-1E296657-55B4-4108-9FA3-937E65219952Q27002288-0EB1C3CC-8C0A-4C26-82F9-CFAC9AD66365Q28074478-3C40CEA6-9008-49B1-B2E0-4E560DA0822CQ28468617-0ECFB234-1EAB-4A8F-8F2C-FD0F0351C610Q33509293-729D2D39-1B3F-4D02-A439-CCDC0F0C9D1DQ33890280-A798934C-893C-41F8-9199-2FD39A9735EFQ33932835-863EB02F-4EBD-4CC4-8893-DB49FE085FAAQ34786512-66864FEB-B7CB-4F88-9C70-2B44E15E2003Q34940971-6F7D7884-9CA9-4450-8ED2-AC222B59C103Q34982347-09FD8C01-31B5-438F-B07E-EF20808CAA94Q35033660-D66C8754-4EDA-4098-BB04-6E0B21849AF0Q35536589-591F7A32-A0BC-453D-850D-6488D38C326FQ35611271-AF68FB13-55DB-44F0-B73B-07DBDDD20079Q35713747-C84A075C-9390-48A0-A727-46099BC16E55Q36048511-78BE8E25-0EA8-4F9C-B40D-DE86ABB24B2CQ36378562-96657D1C-1838-4EC5-87D9-B866E8149F1DQ37113106-02ABFF51-6C4C-45BA-B74F-7A9433E38342Q37381585-55A95334-8D1F-41BA-A155-F4AAD4EEC053Q37457607-DCCD9289-EBBF-4578-8ACF-B352BCDCC5BDQ37630181-68EE18A2-1E08-4342-AA53-7893D15A99D9Q37972804-101D5DBF-F309-48B1-8470-B8B055C092B6Q37993742-990204E5-1C2A-4EB7-BD51-4BB2093C7BFDQ38048861-45099500-0D61-431C-90B3-E3A86FE2E2D4Q38654010-3F16A1F5-DF5A-44ED-B85B-8D7998D1439CQ38734645-FB1DC4B6-A80D-4C15-BB37-C3C8A5AFF0F7Q38815773-3A77E805-AE00-415B-97D2-A455F5AFEFA4Q39063034-53B5EB96-1AAE-4752-89CB-7B46609FA9CEQ40620117-589E04A6-543C-4282-ABD0-968302BE38FFQ41774349-9E7AE0D5-6C5E-4D51-AC28-F6FFCCC33F79Q42652080-D28A0B9E-2C71-4F33-BE4C-06EF3CC436B5Q46795621-16F54A49-B7AD-422D-AD70-E0E882F88C35Q47101032-8F9CEC65-BD02-48AD-B5CC-5908C8779C81Q47387460-968701A1-F972-4190-9748-A70EA6BD65A3Q50067468-0EE023A5-226F-4377-B0C4-042DF5A25853Q53282153-5CACDC09-93E3-43CA-84BC-9667F051E709Q58738641-3F8B5FC2-A26E-4CB7-99A5-2627B797BEDBQ58740348-E2A1E76A-BBE3-4C92-936F-85C4FCAA0843
P2860
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
@en
type
label
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
@en
prefLabel
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
@en
P2093
P50
P1433
P1476
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma.
@en
P2093
Annamaria Venturi
Arianna Lanzi
Luigi Bolondi
Matteo Ravaioli
P304
P356
10.1111/J.1478-3231.2007.01544.X
P577
2007-09-01T00:00:00Z